Hypermarcas (OTCMKTS:HYPMY) Shares Up 6.2% – Still a Buy?

Shares of Hypermarcas (OTCMKTS:HYPMY – Get Free Report) rose 6.2% during mid-day trading on Tuesday. The company traded as high as $4.10 and last traded at $4.10. 958 shares traded hands during trading, a decline of 98% from the average daily volume of 46,290 shares. The stock had previously closed at $3.86.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Hypermarcas currently has a consensus rating of “Buy”.

View Our Latest Stock Report on Hypermarcas

Hypermarcas Stock Performance

The business has a 50-day moving average of $4.60 and a two-hundred day moving average of $4.39. The company has a market cap of $2.75 billion, a P/E ratio of 7.50 and a beta of 0.78. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.86 and a quick ratio of 1.26.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last announced its earnings results on Wednesday, November 11th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.01. The company had revenue of $473.13 million during the quarter, compared to the consensus estimate of $450.75 million. Hypermarcas had a net margin of 20.07% and a return on equity of 12.58%. On average, sell-side analysts predict that Hypermarcas will post 0.50 EPS for the current fiscal year.

About Hypermarcas

(Get Free Report)

Hypermarcas was a Brazilian consumer-products and pharmaceutical company that later adopted the name Hypera Pharma. The company refocused its operations on pharmaceuticals after divesting a number of businesses in other consumer-goods categories. Today, Hypera Pharma develops, manufactures and markets medicines in Brazil, including prescription drugs, over-the-counter products and branded generics. Its portfolio also includes vitamins and supplements, and it sells products under brands such as Neo Química and Mantecorp.

Recommended Stories

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.